Teleflex Incorporated (NYSE:TFX - Get Free Report) shares saw an uptick in trading volume on Friday . 198,983 shares were traded during mid-day trading, a decline of 48% from the previous session's volume of 381,010 shares.The stock last traded at $192.46 and had previously closed at $192.00.
Analyst Ratings Changes
Several brokerages have recently weighed in on TFX. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a report on Friday, November 1st. Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a report on Friday, August 2nd. Truist Financial restated a "hold" rating and set a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Friday, November 1st. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $259.25.
Check Out Our Latest Stock Analysis on Teleflex
Teleflex Stock Up 0.4 %
The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $8.96 billion, a PE ratio of 38.34, a P/E/G ratio of 1.96 and a beta of 1.18. The stock's fifty day simple moving average is $219.90 and its 200-day simple moving average is $222.41.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to analysts' expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the previous year, the company earned $3.64 earnings per share. As a group, sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's payout ratio is 27.04%.
Institutional Investors Weigh In On Teleflex
A number of hedge funds have recently made changes to their positions in the business. Cromwell Holdings LLC increased its position in Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock worth $33,000 after buying an additional 49 shares during the last quarter. Avior Wealth Management LLC raised its stake in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock valued at $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Teleflex during the third quarter valued at about $40,000. True Wealth Design LLC boosted its position in Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock worth $41,000 after purchasing an additional 166 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company's stock valued at $42,000 after purchasing an additional 97 shares during the period. 95.62% of the stock is currently owned by institutional investors.
About Teleflex
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Recommended Stories
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
